Co-Founder and CEO, Wetpaint
Founder and CEO, Lighter Capital
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder and CEO of Brooks Bell Inc.
The National Cancer Institute recently introduced the Small Business Innovation Research (SBIR) Phase II Bridge Award mechanism, which is intended to offer an incentive to phase II awardees who obtain third party financing in order commercialize technologies developed with SBIR funds. Michael Weingarten, director of the SBIR Development Center at the National Cancer Institute, and program director Ali Andalibi will provide an overview of the program. Online registration is here.